“The patient who achieved more than 18 years of complete remission after the infusion never required any other cancer treatment.”
One child treated with CAR-T in 2006 has been cancer-free for 18 years. Of 19 children in the trial, 12 died within seven years. Fifteen-year overall survival is 37%. The headline is about one patient.